A case report of metastatic ovarian cancer presenting as acute abdomen with obstructed umbilical hernia
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20264024Keywords:
Sertoli leydig cell tumour, Ovarian sex cord stromal tumour, Heterologous differentiation, Postmenopause, Obstructed umbilical herniaAbstract
Sertoli-Leydig cell tumours (SLCTs) are rare ovarian sex cord-stromal neoplasms, accounting for less than 0.5% of ovarian tumours. They predominantly occur in young women and are frequently associated with androgenic manifestations. Advanced-stage disease in elderly postmenopausal women is exceptionally uncommon. Here , we present a 76-year-old postmenopausal woman with acute abdominal pain and vomiting due to an obstructed, irreducible umbilical hernia. Emergency laparotomy revealed a friable omental mass within the hernial sac, approximately 2 L of ascites and a large 15×15 cm left ovarian mass densely adherent to the rectosigmoid, bladder, uterus, pelvic sidewall and abdominal wall, with multiple peritoneal tumour deposits. Frozen section showed a poorly differentiated malignant neoplasm, with carcinosarcoma considered. Comprehensive cytoreductive surgery including total abdominal hysterectomy, bilateral salpingo-oophorectomy, peritonectomy, omentectomy, rectosigmoid resection and lymph-node assessment was performed. Definitive histopathology demonstrated a poorly differentiated (Grade 3) Sertoli-Leydig cell tumour with heterologous mucinous and cartilaginous differentiation. The tumour showed surface involvement and rupture, parametrial involvement and extrapelvic peritoneal deposits, with negative regional lymph nodes. No virilising features were documented. This case highlights an exceptionally rare presentation of advanced poorly differentiated SLCT in a postmenopausal woman, masquerading as an acute surgical abdomen due to an obstructed umbilical hernia. SLCT should be considered in the differential diagnosis of ovarian malignancy even in elderly women without androgenic manifestations. Heterologous differentiation may mimic epithelial ovarian carcinoma or carcinosarcoma on frozen section, underscoring the importance of definitive histopathological and immunohistochemical evaluation.
References
Muscat C, Calleja-Agius J. Review on Sertoli-Leydig cell tumours of the ovary. Discov Med. 2024;36(181):234-47.
Gressel GM, Buza N, Pal L. Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature. Eur J Gynaecol Oncol. 2017;38(2):214-20.
Durmuş Y, Kılıç Ç, Çakır C, Yüksel D, Boran N, Karalök A, et al. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database and review of the literature. J Obstet Gynaecol Res. 2019;45(7):1311-8.
Young RH. Sertoli-Leydig cell tumors of the ovary: review with emphasis on historical aspects and unusual variants. Int J Gynecol Pathol. 1993;12(2):141-7.
National Cancer Institute. SEER training modules: ovarian cancer staging. Bethesda (MD): National Cancer Institute; updated 2018. Available from: https://www.training.seer.cancer.gov/ovarian/abstract-code-stage/staging.html Accessed on 18 August 2026.
Bhat RA, Lim YK, Chia YN, Yam KL. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database. J Obstet Gynaecol Res. 2013;39(1):305-10.
Gheorghisan-Galateanu A, Fica S, Terzea DC, Caragheorgheopol A, Horhoianu V. Sertoli-Leydig cell tumor: a rare androgen-secreting ovarian tumor in postmenopausal women. J Cell Mol Med. 2003;7(4):461-71.
Singh C, Ahmad S, Hajjar FM, Holloway RW. Poorly differentiated ovarian Sertoli-Leydig cell tumor with heterologous rhabdomyosarcoma and glandular elements: diagnosis and management of a rare neoplasm. Gynecol Oncol Rep. 2018;25:70-3.
Brightwell R, Grzankowski K, Kasznica J, Frederick PJ. Poorly differentiated Sertoli-Leydig tumor with heterologous, high-grade, sarcomatoid features: a case report. Gynecol Oncol Rep. 2015;14:6-8.
Xiao H, Li B, Zuo J, Feng X, Li X, Zhang R, et al. Ovarian Sertoli-Leydig cell tumor: a report of seven cases and a review of the literature. Gynecol Endocrinol. 2013;29(3):192-5.
Karabulut Z, Aydın Ö, Onur E, Çelik NY, Moray G. Giant ovarian tumor presenting as an incarcerated umbilical hernia: a case report. J Korean Med Sci. 2009;24(3):539-41.
Millar RC, Geelhoed GW, Ketcham AS. Ovarian cancer presenting as umbilical hernia. J Surg Oncol. 1975;7(6):493-6.
Varga-Szabó D, Papadakis M, Pröpper S, Zirngibl H. Primary peritoneal adenocarcinoma as content of an incarcerated umbilical hernia: a case-report and review of the literature. Int J Surg Case Rep. 2016;19:134-6.
Rojewska P, Meczekalski B, Bala G, Luisi S, Podfigurna A. From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach. Gynecol Endocrinol. 2022;38(7):537-42.
Nef J, Huber DE. Ovarian Sertoli-Leydig cell tumours: a systematic review of relapsed cases. Eur J Obstet Gynecol Reprod Biol. 2021;263:261-74.
Tokunaga H, Mikami M, Nagase S, Kobayashi Y, Tabata T, Kaneuchi M, et al. The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. J Gynecol Oncol. 2021;32(2):e49.
Friedlander ML, Anderson L, Lee YC. Controversies in the management of ovarian granulosa cell and Sertoli-Leydig cell tumors. Int J Gynecol Cancer. 2025;35(3):101668.
Colombo N, Peiretti M, Garbi A, Carinelli S, Marini C, Sessa C; ESMO Guidelines Working Group. Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7:vii20-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 B. Ramesh, Lovelin Kashyap

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.